Abstract:Alzheimer's disease (AD) is the most common form of dementia, and the molecular mechanisms that underlie AD pathophysiology remain unclear. AMP-activated protein kinase (AMPK) is a Ser/Thr kinase that functions as a central energy sensor to maintain cellular energy homeostasis. Furthermore, AMPK integrates several signaling pathways controlling de novo protein synthesis (mRNA translation) which is vital for long-term synaptic plasticity and memory formation. Dysregulation of energy homeostasis and de novo protein synthesis are both implicated in AD. AMPK is a heterotrimeric protein with a catalytic α subunit and regulatory β/γ subunit. The α subunit of AMPK exists in two isoforms: α1 and α2, and their roles in AD are unknown. Post Mortem brain tissue from human AD was examined by both western blot and immunohistochemistry for AMPKα1 and AMPKα2 levels. AMPKα1 protein levels were selectively reduced in late development in the forebrain of Tg19959 AD model mice to generate AMPKα1(+/-)/Tg19959 double mutant mice. These mice were cognitively assessed by Morris Water Maze (MWM) and Novel Object Recognition (NOR) tasks. Hippocampal long-term potentiation (LTP) was measured to assess synaptic plasticity, moreover dendritic spine morphology was examined by Golgi Stain. In human hippocampal tissue AMPKα1 levels were dramatically increased, while levels of AMPKα2 were decreased in comparison with age-matched controls. These changes were neuronally localized and AD hippocampi specific. AD associated impairments of cognition and synaptic plasticity were alleviated in AMPKα1(+/-)/Tg19959 double mutant mice. Analysis of dendritic spine morphology revealed the hippocampal abnormalities in theTg19959 model mice were restored with genetic reduction of AMPKα1. AMPKα1 is abnormally neuronally upregulated in AD. Our results demonstrate that restoration of AMPKα1 levels in an AD model mouse ameliorates the behavioral and synaptic plasticity impairments. Our findings indicate AMPKα1 dysregulation as a molecular mechanism underlying AD pathophysiology, and providing insights into a potential therapeutic strategy.

Maged1 Co-interacting with CREB Through a Hexapeptide Repeat Domain Regulates Learning and Memory in Mice

Calmodulin Shuttling Mediates Cytonuclear Signaling to Trigger Experience-Dependent Transcription and Memory

Maf1 loss regulates spinogenesis and attenuates cognitive impairment in Alzheimer's disease

The Deficiency of Maged1 Attenuates Parkinson's Disease Progression in Mice

DREAM (downstream Regulatory Element Antagonist Modulator) Contributes to Synaptic Depression and Contextual Fear Memory

AIM2 Deletion Promotes Neuroplasticity and Spatial Memory of Mice

Upregulation of CREB-Mediated Transcription Enhances Both Short- and Long-Term Memory

Fragile X Mental Retardation Protein is Required for Chemically‐induced Long‐term Potentiation of the Hippocampus in Adult Mice

Impaired Hippocampal Long-Term Potentiation and Memory Deficits upon Haploinsufficiency of MDGA1 Can Be Rescued by Acute Administration of D-Cycloserine

Maf1 regulates dendritic morphogenesis and influences learning and memory

Conditional deletion of MAD2B in forebrain neurons enhances hippocampus-dependent learning and memory in mice

GSK-3β Deletion in Dentate Gyrus Excitatory Neuron Impairs Synaptic Plasticity and Memory

P2‐157: BRAIN‐SPECIFIC REPRESSION OF AMPKα1 ALLEVIATES MEMORY DEFICITS AND SYNAPTIC FAILURE IN A MOUSE MODEL OF ALZHEIMER'S DISEASE

Contrasting Functions of Mitogen- and Stress-activated Protein Kinases 1 and 2 in Recognition Memory and In Vivo Hippocampal Synaptic Transmission

Genetic Enhancement of Learning and Memory in Mice.

Over‐expressed MST1 Impaired Spatial Memory Via Disturbing Neural Oscillation Patterns in Mice

Mecp2 Deficiency in Peripheral Sensory Neuron Improves Cognitive Function by Enhancing Hippocampal Dendritic Spine Densities in Mice

M1 Muscarinic Receptor Activation Rescues β-Amyloid-Induced Cognitive Impairment through AMPA Receptor GluA1 Subunit.

MAGED1 is a Negative Regulator of Bone Remodeling in Mice

MEF2C ameliorates learning, memory, and molecular pathological changes in Alzheimer’s disease <italic>in vivo</italic> and<?A3B2 ACK?><italic>in vitro</italic>

Forebrain-specific constitutively active CaMKKα transgenic mice show deficits in hippocampus-dependent long-term memory.